Impact of Immunoscore on the Management of Stage II Colon Cancer Patients: A Physician Survey

Impact of Immunoscore on the Management of Stage II Colon Cancer Patients: A Physician Survey

Background: Adjuvant chemotherapy use in stage II colon cancer is controversial. Current prognostic risk factors do not take the tumor immune microenvironment into account. Consideration of the Immunoscore, which measures the host immune response at the tumor site, may assist clinicians in reducing...

Full description

Bibliographic Details
Main Authors: Anup Kasi, Efrat Dotan, Graham M. Poage, Aurelie Catteau, Dewi Vernerey, Manju George, Afsaneh Barzi
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cancers
Subjects:
colonic neoplasms
oncologists
surveys and questionnaires
prognosis
tumor microenvironment
Online Access:https://www.mdpi.com/2072-6694/13/21/5467

Internet

https://www.mdpi.com/2072-6694/13/21/5467

Similar Items